Clinicians’ self-reported efficacy in cardiovascular prevention practice in the southeastern United States

Trevor Caldarera, Cynthia Ponir, Austin Seals, Megha Penmetsa, Edward Ip, Charles A. German, Salim S. Virani, Animita Saha, Hayden B. Bosworth, Justin B. Moore, Michael D. Shapiro, Yashashwi Pokharel

Research output: Contribution to journalArticlepeer-review


Aim: We assessed self-reported efficacy in cardiovascular prevention practice among internal medicine, family medicine, endocrinology and cardiology clinicians. Patients & methods: We emailed a 21-item questionnaire to 956 physicians, nurse practitioners, physician assistants and pharmacists. Results: 264 clinicians responded (median age: 39 years, 55% women, 47.9% specialists). Most expressed high self-efficacy in lifestyle counselling, prescribing statins, metformin, and aspirin in primary prevention, but low self-efficacy in managing specialized conditions like elevated lipoprotein(a). Compared with specialists, PCPs expressed lower self-efficacy in managing advanced lipid disorders and higher self-efficacy in prescribing sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists. Conclusion: Self-efficacy in cardiovascular prevention varied across specialties. Future research should explore relevant provider, clinic and system level factors to optimize cardiovascular prevention.

Original languageEnglish
Pages (from-to)593-604
Number of pages12
JournalFuture Cardiology
Issue number12
Publication statusPublished - 1 Sept 2023


  • atherosclerotic disease
  • cardiovascular prevention
  • multidisciplinary care
  • self-efficacy
  • translational medicine


Dive into the research topics of 'Clinicians’ self-reported efficacy in cardiovascular prevention practice in the southeastern United States'. Together they form a unique fingerprint.

Cite this